Talphera (NASDAQ:TLPH) Trading Up 1.9% – Still a Buy?

Talphera, Inc. (NASDAQ:TLPH)’s stock price traded up 1.9% during trading on Thursday . The company traded as high as $1.10 and last traded at $1.07. 426,577 shares traded hands during mid-day trading, an increase of 66% from the average daily volume of 257,145 shares. The stock had previously closed at $1.05.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on TLPH shares. Zacks Research raised Talphera to a “hold” rating in a research note on Monday, June 8th. Westpark Capital initiated coverage on Talphera in a research note on Thursday, April 30th. They set a “buy” rating and a $3.00 price objective for the company. Weiss Ratings restated a “sell (d-)” rating on shares of Talphera in a report on Monday, April 20th. Finally, HC Wainwright initiated coverage on shares of Talphera in a research note on Friday, June 5th. They issued a “buy” rating and a $3.00 target price on the stock. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $3.00.

Talphera Stock Performance

The business has a 50-day simple moving average of $0.88 and a 200 day simple moving average of $0.90. The firm has a market cap of $55.53 million, a P/E ratio of -3.45 and a beta of 0.70.

Talphera (NASDAQ:TLPH) last released its quarterly earnings data on Wednesday, May 13th. The company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.03. On average, research analysts expect that Talphera, Inc. will post -0.26 EPS for the current year.

Institutional Trading of Talphera

Several large investors have recently added to or reduced their stakes in the stock. Rosalind Advisors Inc. raised its holdings in Talphera by 118.9% in the 3rd quarter. Rosalind Advisors Inc. now owns 4,385,757 shares of the company’s stock worth $3,917,000 after purchasing an additional 2,381,818 shares in the last quarter. Nantahala Capital Management LLC boosted its stake in shares of Talphera by 75.3% during the 3rd quarter. Nantahala Capital Management LLC now owns 3,492,519 shares of the company’s stock valued at $3,120,000 after purchasing an additional 1,500,000 shares in the last quarter. Empery Asset Management LP bought a new stake in shares of Talphera during the 4th quarter valued at about $1,520,000. Cantor Fitzgerald L. P. purchased a new position in shares of Talphera during the fourth quarter valued at about $658,000. Finally, Renaissance Technologies LLC increased its position in shares of Talphera by 412.6% during the fourth quarter. Renaissance Technologies LLC now owns 257,380 shares of the company’s stock valued at $293,000 after buying an additional 207,166 shares during the period. Institutional investors own 37.67% of the company’s stock.

Talphera Company Profile

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.